In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

See also:

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. May 06, 2022

    Pharmacies Face Key Trial Test As Opioid MDL Intrigue Swirls

    America's biggest pharmacy chains are poised for a pivotal trial at the center of multidistrict opioid litigation and the opioid crisis itself, aiming to avert a giant judgment and an enormous expansion of their broader liability in thousands of cases that are suddenly threatening to spiral out of control.

  2. April 27, 2022

    COVID-19 Cases Won't Stop SF's Opioid Bellwether Trial

    The California federal judge presiding over a multibillion-dollar bellwether bench trial on San Francisco's claim that Walgreens, Teva, Allergan and Anda illegally fueled its opioid crisis said Wednesday the trial will proceed despite individuals from both sides testing positive for COVID-19, calling it "an important case for everybody."

  3. April 27, 2022

    'Overheated Hyperbole'? Opioid Atty Gets Fiery In SF Trial

    Two days of opening statements in San Francisco's opioid crisis trial featured impassioned assertions about the pharmaceutical industry's role in rampant drug abuse, but a Foley & Lardner attorney stole the show with invective so intense that he cautioned the judge against ignoring it as "overheated hyperbole" from an overzealous advocate.

  4. April 26, 2022

    'Small Fish' Drugmakers Blame Purdue In SF Opioid Trial

    Drugmakers Teva and Allergan deflected blame for San Francisco's opioid crisis in opening statements of a multibillion-dollar bellwether bench trial Tuesday, saying they're "small fish" responsible for a "minuscule portion" of the city's opioids, and pointing to bankrupt Purdue Pharma as the true culprit.

  5. April 25, 2022

    SF Opens Key Opioid Bellwether Trial Vowing To Reveal 'Lies'

    The city of San Francisco kicked off an epic multibillion-dollar bellwether bench trial Monday in its suit alleging drugstore chain Walgreens, drugmakers Teva and Allergan and distributor Anda illegally fueled the opioid epidemic, promising to reveal "the myths, the lies and the misleading statements" that fed the crisis and ravaged the city.

  6. April 21, 2022

    Bellwether By The Bay: Key Details As SF Opioid Trial Looms

    Amid thousands of opioid crisis lawsuits, one of the biggest bellwether trials so far — a seismic showdown in San Francisco federal court — is set to shake up the opioid litigation landscape with an in-depth exploration of the pharmaceutical industry's role in drug abuse overrunning a major American city.

  7. April 20, 2022

    Endo Reaches $10M Deal With SF Ahead Of Opioid Trial

    Endo Pharmaceuticals has agreed to pay $10 million over the course of 10 years to resolve the city of San Francisco's claims stemming from the drugmaker's role in the opioid crisis, a deal that comes just days before the company's bellwether bench trial was set to kick off in California federal court, according to an announcement Wednesday.  

  8. April 12, 2022

    Mapping The Top Trials To Know In The Opioid Litigation Wave

    Opioid crisis lawsuits against major companies in the pharmaceutical supply chain are heating up in large numbers, producing a byzantine brew of battles in courts all across America. Here, Law360 provides a map that will continue to track completed, ongoing and upcoming trials.

  9. April 09, 2022

    In Surprise Move, Panel Stops Adding Cases To Opioid MDL

    The Judicial Panel on Multidistrict Litigation unexpectedly ruled late Friday that a huge and historic MDL for opioid crisis lawsuits against pharmaceutical companies has accomplished key objectives and doesn't offer enough remaining upsides to warrant the addition of future cases.

  10. April 08, 2022

    Big Pharma Can't Beat SF Opioid Claims Before Trial

    Teva Pharmaceuticals, Allergan, Anda Inc. and other drugmakers and distributors can't escape San Francisco's claims in an upcoming bellwether bench trial, the California federal judge overseeing the multidistrict opioid litigation has ruled, but Endo International can beat allegations attributed to its subsidiaries.